SCHEMBL354378

SCHEMBL354378

CC(=O)N=C1C=CC(=O)C=C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 1/20 1.00
▸ ALDH1A1 P00352 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ MDM2 Q00987 1/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ APOBEC3G Q9HC16 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TXNRD1 Q16881 1/20 0.35
▸ TXNRD3 Q86VQ6 1/20 0.35
▸ TXNRD2 Q9NNW7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14625722 0.75 MIF (0.60) MIFALDH1A1BCHEPOLBMAOA
Benzoquinone SCHEMBL7548542 0.72 ALDH1A1 (0.57) MIFALDH1A1BCHEPOLBMAOA
Benzoquinone SCHEMBL1916998 0.72 ALDH1A1 (0.57) MIFALDH1A1BCHEPOLBMAOA
SCHEMBL5161488 0.70 MIF (0.54) MIFALDH1A1BCHEPOLBMAOA
SCHEMBL18483030 0.68 MIF (0.52) MIFALDH1A1BCHEPOLBMAOA
Benzoquinone SCHEMBL9457254 0.67 TDP1 (0.73) MIFALDH1A1BCHEPOLBMAOA
SCHEMBL232995 0.67 — —
Benzoquinone SCHEMBL31324203 0.67 ALDH1A1 (0.89) MIFALDH1A1BCHEPOLBMAOA
SCHEMBL12330836 0.67 — —
Benzoquinone SCHEMBL31324224 0.67 ALDH1A1 (0.89) MIFALDH1A1BCHEPOLBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 989 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695383-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LIVER FAILURE University of Massachusetts (US) 2026-02-18 — — EP claimed
US-20250339391-A1 METHODS FOR EFFECTIVE MANAGEMENT OF PAIN South Rampart Pharma, Inc. (US) 2025-11-06 — — US claimed
CN-119061403-A Aluminum bronze cleaning polishing solution, preparation method and polishing method 江苏汉宜新材料有限公司 2024-12-03 — — CN claimed
US-20240368669-A1 ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF BIOVENTURES, LLC 2024-11-07 — — US claimed
WO-2024216032-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LIVER FAILURE UNIVERSITY OF MASSACHUSETTS (US) 2024-10-17 — — WO claimed
CN-117766159-A Non-steroidal anti-inflammatory drug and liver toxicity risk assessment method of metabolite thereof based on network architecture analysis 重庆医科大学 2024-03-26 — — CN claimed
EP-3672938-B1 COMPOUNDS FOR AMELIORATING PAIN THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2023-11-01 — — EP claimed
US-11633371-B2 Deuterated forms of acetaminophen and uses thereof Lennham Pharmaceuticals, Inc. (US) 2023-04-25 — — US claimed
US-20230082397-A1 ACETAMINOPHEN COMPOUND COMPOSITION WITHOUT SIDE EFFECT TO LIVER NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION (TW) 2023-03-16 — — US claimed
US-11534416-B2 Hepatotoxicity-free pharmaceutical composition containing acetaminophen drugs NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION (TW) 2022-12-27 — — US claimed
CN-112294800-A Application of ellagic acid in preparing medicine for preventing and/or treating nonalcoholic fatty liver disease and liver injury 四川大学 2021-02-02 — — CN claimed
WO-2019200343-A1 S6K2 BLOCKADE PERTURBS REDOX BALANCE AND FATTY ACID METABOLISM, LEADING TO OXIDATIVE CELL DEATH IN MAPK INHIBITOR RESISTANT CANCERS THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2019-10-17 — — WO claimed
EP-3104849-B1 ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF BIOVENTURES LLC (US) 2019-08-28 — — EP claimed
US-10104882-B2 Methods and compositions for preventing and treating electrophile-mediated toxicities MONTEFIORE MEDICAL CENTER (US) 2018-10-23 — — US claimed
US-20170246194-A1 Acetaminophen-Containing Analgesic Formulations With Reduced Hepatotoxicity PURDUE PHARMA L.P. (US) 2017-08-31 — — US claimed
EP-3104849-A1 ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF The Board of Trustees of the University of Arkansas (US) 2016-12-21 — — EP claimed
WO-2016025897-A1 ACETAMINOPHEN-CONTAINING ANALGESIC FORMULATIONS WITH REDUCED HEPATOTOXICITY PURDUE PHARMA L.P. (US) 2016-02-18 — — WO claimed
WO-2015123574-A1 ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2015-08-20 — — WO claimed
CN-102149412-A Hepatoprotectant acetaminophen mutual prodrugs NEUROGESX INC 2011-08-10 — — CN claimed
US-5474757-A Administering diallyl sulfone to prevent metabolism of acetaminophen into hepatotoxic metabolites RUTGERS UNIVERSITY (US) 1995-12-12 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250339391-A1 METHODS FOR EFFECTIVE MANAGEMENT OF PAIN SRP72, OPRL1, OPRK1 MIF 3445/4885ALDH1A1 2342/4885BCHE 2837/4885
US-10104882-B2 Methods and compositions for preventing and treating electrophile-mediated toxicities GSTK1, CPT1A, GOT2 MIF 2068/4885ALDH1A1 125/4885BCHE 1157/4885
US-11633371-B2 Deuterated forms of acetaminophen and uses thereof CYP2D6, CYP2E1, HPGD MIF 2177/4885ALDH1A1 322/4885BCHE 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback